MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2016 International Congress

    The clinical significance of brain microbleed in Alzheimer’s disease patients with Parkinsonian signs

    J.Y. Ahn, H.T. Kim (Seoul, Korea)

    Objective: We investigated the clinical significance of brain microbleeds in Alzheimer's disease patients with MPS comparing patients without MPS. Background: Microbleeds(MBs) were observed frequently in…
  • 2016 International Congress

    Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists

    M.E. Mohammad, J.A. Vizcarra, K. O'Donnell, S. Patel, X. Garcia, X.X. Yu, K. Vlastaris, K. Sutton, H.H. Fernandez (Cleveland, OH, USA)

    Objective: To evaluate the clinician response to Parkinson patients who developed behavioral side effects from dopamine agonists. Background: Side effects from dopamine agonists can be…
  • 2016 International Congress

    The effect of anodal transcranial direct current stimulation (tDCS) on sequential motor skill learning in persons with Parkinson’s disease

    E. Kerckhofs, N. Deroost (Brussels, Belgium)

    Objective: To examine the potential effect of tDCS on the acquisition of implicit sequential motor skill learning in persons with PD (pwPD). Background: Due to…
  • 2016 International Congress

    Temporal working memory deficit in Parkinson’s disease

    B. Degos, I. Ameqrane, S. Rivaud-Péchoux, P. Pouget, M. Missal (Paris, France)

    Objective: To investigate whether temporal working memory (TWM) could be impacted in Parkinson's disease (PD). We also tested whether idiopathic PD patients (iPD) could be…
  • 2016 International Congress

    Eye tracking-based measurement of cognitive functions in patients with neurodegenerative diseases

    H. Schmitz-Peiffer, K. Linse, W. Rüger, M. Joos, M. Löhle, A. Storch, A. Hermann (Dresden, Germany)

    Objective: To develop and evaluate motor-free procedures via eye tracking for determining cognitive functions in patients with idiopathic Parkinson's disease (PD) and motor neuron disease…
  • 2016 International Congress

    Impaired cube copy on the MOCA indicates worse performance in several cognitive domains in Parkinson´s disease

    C. Gasca-Salas, M. Cohn, J.A. Pineda, J.A. Obeso (Madrid, Spain)

    Objective: We aimed to identify if an impairment of the cube copy of the Montreal Cognitive assessment (MoCA) was associated with worse cognitive status in…
  • 2016 International Congress

    Effects of dual task on upper extremity function and postural control in patients with Parkinson’s disease

    S.M.A.A. Pompeu, B.R.B. Moraes, J.E. Pompeu (São Paulo, Brazil)

    Objective: To verify the performance and pattern of prioritization of patients with Parkinson's disease in motor and cognitive dual tasks with different demands. Background: Patients…
  • 2016 International Congress

    Cognitive functioning in Parkinson’s disease and Parkinson plus syndrome

    S. Mina, V.K. Verma, K.S. Anand (New Delhi, India)

    Objective: Our study aimed to investigate and compare the cognitive functioning in PD and PPS. Background: Parkinson[s] disease (PD) is now known to be associated…
  • 2016 International Congress

    Cognitive decline in Parkinson’s disease: Impact on quality of life of caregivers

    R.A. Lawson, A.J. Yarnall, G.W. Duncan, F. Johnston, T.K. Khoo, D. Collerton, J.P. Taylor, D.J. Burn (Newcastle upon Tyne, United Kingdom)

    Objective: This study aimed to investigate the impact of cognitive impairment in Parkinson's disease (PD) on the quality of life (QoL) of carers. Background: The…
  • 2016 International Congress

    Association of Parkinson’s disease severity and cortical and subcortical cognitive markers

    H. Duran-Meza, A.D. Santana-Vargas, J.D. Ramirez-Diossa, G.H. Terrazas Gonzalez, G. Millan-Rosas, U. Jimenez-Correa, M. Lopez-Ruiz (Mexico City, Mexico)

    Objective: To assess cortical and subcortical dysfunction in several stages of Parkinson's disease (PD) using the Parkinson's disease-cognitive rating scale (PD-CRS). Background: Cognitive impairment in…
  • « Previous Page
  • 1
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley